Global Genetic Stability Testing Market Growth (Status and Outlook) 2025-2031

The global Genetic Stability Testing market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Gene stability testing refers to a series of experiments that evaluate the stability of exogenous genes in host cells. In genetic engineering, the stability of exogenous genes is one of the important factors affecting gene expression level and genetic stability after being introduced into host cells. Gene stability testing can evaluate the stability of exogenous genes by detecting their copy number in cells, stability of insertion sites, and stability of gene expression, among others. These tests are crucial for assessing the quality and safety of genetic engineering products, particularly in the fields of gene therapy and gene editing.

Gene stability testing typically involves multiple techniques, such as PCR, Southern blotting, flow cytometry, and fluorescence in situ hybridization (FISH). PCR can be used to detect the copy number of exogenous genes in cells; Southern blotting can be used to detect the stability of insertion sites of exogenous genes; flow cytometry can be used to detect the stability of gene expression; and FISH can be used to detect the binding of exogenous genes and chromosomes. Through the application of these techniques, a comprehensive assessment of the stability of exogenous genes in host cells can be achieved.

United States market for Genetic Stability Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Genetic Stability Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Genetic Stability Testing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Genetic Stability Testing players cover Molecular Diagnostic Services, Inc. (MDS), ViruSure, Eurofins BioPharma Product Testing, Charles River, Creative Biolabs, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Genetic Stability Testing Industry Forecast” looks at past sales and reviews total world Genetic Stability Testing sales in 2024, providing a comprehensive analysis by region and market sector of projected Genetic Stability Testing sales for 2025 through 2031. With Genetic Stability Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genetic Stability Testing industry.

This Insight Report provides a comprehensive analysis of the global Genetic Stability Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Genetic Stability Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Genetic Stability Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genetic Stability Testing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genetic Stability Testing.

This report presents a comprehensive overview, market shares, and growth opportunities of Genetic Stability Testing market by product type, application, key players and key regions and countries.

Segmentation by Type:

Animal

Plant

Microorganism

Segmentation by Application:

Agricultural

Food & Beverage

Bio-pharmaceutical

Medical Research

Others

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Molecular Diagnostic Services, Inc. (MDS)

ViruSure

Eurofins BioPharma Product Testing

Charles River

Creative Biolabs

CD BioSciences

Sartorius

WuXi Advanced Therapies

Thermo Fisher Scientific

Merck

Please note: The report will take approximately 2 business days to prepare and deliver.